Jupiter Neurosciences, Common Stock EBITDA
| JUNS Stock | USD 9.73 1.13 10.41% |
Jupiter Neurosciences, Common fundamentals help investors to digest information that contributes to Jupiter Neurosciences,'s financial success or failures. It also enables traders to predict the movement of Jupiter Stock. The fundamental analysis module provides a way to measure Jupiter Neurosciences,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Jupiter Neurosciences, stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -4.6 M | -4.8 M |
Jupiter | EBITDA |
Jupiter Neurosciences, Common Company EBITDA Analysis
Jupiter Neurosciences,'s EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Jupiter Neurosciences, EBITDA | (4.56 M) |
Most of Jupiter Neurosciences,'s fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Jupiter Neurosciences, Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Jupiter EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Jupiter Neurosciences, is extremely important. It helps to project a fair market value of Jupiter Stock properly, considering its historical fundamentals such as EBITDA. Since Jupiter Neurosciences,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Jupiter Neurosciences,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Jupiter Neurosciences,'s interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Jupiter Ebitda
Ebitda |
|
According to the company disclosure, Jupiter Neurosciences, Common reported earnings before interest,tax, depreciation and amortization of (4.56 Million). This is 100.52% lower than that of the Healthcare sector and 104.56% lower than that of the Biotechnology industry. The ebitda for all United States stocks is 100.12% higher than that of the company.
Jupiter EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Jupiter Neurosciences,'s direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Jupiter Neurosciences, could also be used in its relative valuation, which is a method of valuing Jupiter Neurosciences, by comparing valuation metrics of similar companies.Jupiter Neurosciences, is currently under evaluation in ebitda category among its peers.
Jupiter Fundamentals
| Current Valuation | 202.55 M | ||||
| EBITDA | (4.56 M) | ||||
| Net Income | (4.78 M) | ||||
| Total Debt | 2.25 M | ||||
| Cash Flow From Operations | (480.95 K) | ||||
| Market Capitalization | 200.22 M | ||||
| Total Asset | 148.59 K | ||||
| Retained Earnings | (23.58 M) | ||||
| Net Asset | 148.59 K |
About Jupiter Neurosciences, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Jupiter Neurosciences, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jupiter Neurosciences, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jupiter Neurosciences, Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Jupiter Stock Analysis
When running Jupiter Neurosciences,'s price analysis, check to measure Jupiter Neurosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jupiter Neurosciences, is operating at the current time. Most of Jupiter Neurosciences,'s value examination focuses on studying past and present price action to predict the probability of Jupiter Neurosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jupiter Neurosciences,'s price. Additionally, you may evaluate how the addition of Jupiter Neurosciences, to your portfolios can decrease your overall portfolio volatility.